- Home
- ARQT vs FWRG Comparison
ARQT vs FWRG Comparison
Compare ARQT & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- FWRG
- Stock Information
- Founded
- ARQT 2016
- FWRG 1983
- Country
- ARQT United States
- FWRG United States
- Employees
- ARQT N/A
- FWRG N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- FWRG Restaurants
- Sector
- ARQT Health Care
- FWRG Consumer Discretionary
- Exchange
- ARQT Nasdaq
- FWRG Nasdaq
- Market Cap
- ARQT 1.1B
- FWRG 1.2B
- IPO Year
- ARQT 2020
- FWRG 2021
- Fundamental
- Price
- ARQT $14.99
- FWRG $18.61
- Analyst Decision
- ARQT Strong Buy
- FWRG Strong Buy
- Analyst Count
- ARQT 4
- FWRG 10
- Target Price
- ARQT $15.50
- FWRG $23.50
- AVG Volume (30 Days)
- ARQT 2.2M
- FWRG 701.4K
- Earning Date
- ARQT 11-06-2024
- FWRG 11-07-2024
- Dividend Yield
- ARQT N/A
- FWRG N/A
- EPS Growth
- ARQT N/A
- FWRG N/A
- EPS
- ARQT N/A
- FWRG 0.33
- Revenue
- ARQT $138,708,000.00
- FWRG $997,252,000.00
- Revenue This Year
- ARQT $208.32
- FWRG $16.31
- Revenue Next Year
- ARQT $48.56
- FWRG $15.43
- P/E Ratio
- ARQT N/A
- FWRG $56.20
- Revenue Growth
- ARQT 182.84
- FWRG 19.77
- 52 Week Low
- ARQT $2.60
- FWRG $12.90
- 52 Week High
- ARQT $15.77
- FWRG $25.98
- Technical
- Relative Strength Index (RSI)
- ARQT 67.53
- FWRG 48.54
- Support Level
- ARQT $12.66
- FWRG $18.90
- Resistance Level
- ARQT $15.02
- FWRG $20.18
- Average True Range (ATR)
- ARQT 1.11
- FWRG 0.88
- MACD
- ARQT 0.14
- FWRG -0.17
- Stochastic Oscillator
- ARQT 78.92
- FWRG 27.56
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About FWRG First Watch Restaurant Group Inc.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.